Investigating the In Vitro Immunomodulatory Potential of Microparticulate β-L-Adenosine in Particulate Vaccine Candidates.

For MHC I, BLA MPs with vaccine MPs showed no significant difference with MF59 in H1N1 ( Figure 9 A), Measles ( Figure 9 C), and canine COVID-19 ( Figure 9 D) vaccine microparticles, but they did show a slight significance with Zika ( Figure 9 B) and Gonorrhea ( Figure 9 E) microparticles.

also in 67 other papers